RxDoctor Payments Data

Jon Krueger

Psychiatric/Mental Health · Flint, MINPI 1033473749

Payments from drug & device makers

$2,548in general payments, 2019–2025

Across 137 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$499
  • Johnson & Johnson$458
  • Alkermes, Inc.$394
  • E.r. Squibb & Sons, L.L.C.$274
  • Teva Pharmaceuticals USA, Inc.$240
  • Lundbeck LLC$125
  • plus $558 from 10 others

What the payments were for

  • Food & beverage$2,46897%
  • Education$803%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,548 in reported general payments places this provider in the 75th percentile of 638 psychiatric/mental health providers in Michigan.

See all psychiatric/mental health providers in Michigan

Medicare billing

Part B allowed, 2024
$21,867
Medicare patients
105
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate202$692,430
Invega TrinzaPaliperidone Palmitate37$334,715
Abilify MaintenaAripiprazole81$239,784
FanaptIloperidone100$59,685
AristadaAripiprazole Lauroxil13$40,039
VraylarCariprazine Hcl19$26,382
RexultiBrexpiprazole18$26,269
Divalproex Sodium ErDivalproex Sodium311$23,862
AuvelityDextromethorphan Hbr/Bupropion31$16,898
Chlorpromazine Hcl45$16,078
Clozapine175$15,957
Paliperidone ErPaliperidone115$15,949
Aripiprazole150$13,294
Haloperidol Decanoate228$11,093
Fluphenazine Decanoate82$8,934

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Invega$458$1,031,340250 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$499$266,05399 claims
Vanda Pharmaceuticals Inc.Fanapt$64$59,685100 claims
Alkermes, Inc.Aristada$394$40,03913 claims
AbbVieVraylar$84$26,38219 claims
Axsome Therapeutics, Inc.Auvelity$41$16,89831 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 638 psychiatric/mental health providers in Michigan.

Other psychiatric/mental health in Flint

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →